Cargando…
Fungal infection-related mortality versus total mortality as an outcome in trials of antifungal agents
BACKGROUND: Disease specific mortality is often used as outcome rather than total mortality in clinical trials. This approach assumes that the classification of cause of death is unbiased. We explored whether use of fungal infection-related mortality as outcome rather than total mortality leads to b...
Autores principales: | Due, Anne K, Johansen, Helle K, Gøtzsche, Peter C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559710/ https://www.ncbi.nlm.nih.gov/pubmed/16907965 http://dx.doi.org/10.1186/1471-2288-6-40 |
Ejemplares similares
-
Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations
por: Jørgensen, Karsten J, et al.
Publicado: (2006) -
Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids
por: Lazzarini, Cristina, et al.
Publicado: (2018) -
FUNGAL INFECTIONS, USE OF ANTIFUNGAL AGENTS, AND THE RISK OF ALZHEIMER’S DISEASE
por: Yashkin, Arseniy, et al.
Publicado: (2022) -
The role of the Mediator complex in fungal pathogenesis and response to antifungal agents
por: O'Connor-Moneley, James, et al.
Publicado: (2023) -
Fungal Spectrum and Susceptibility Against Nine Antifungal Agents in 525 Deep Fungal Infected Cases
por: Cai, Wenying, et al.
Publicado: (2023)